Coya Therapeutics Inc.
(COYA)
undefined
undefined%
At close: undefined
5.89
2.26%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | 6.00M | - | - | - |
Cost of Revenue | 27.36K | 27.36K | 16.13K | - |
Gross Profit | 5.97M | -27.36K | -16.13K | - |
Operating Income | -7.90M | -9.81M | -4.87M | -694.77K |
Interest Income | - | - | - | 58.46 |
Pretax Income | -7.26M | -12.24M | -4.89M | -733.20K |
Net Income | -7.99M | -14.68M | -4.87M | -733.20K |
Selling & General & Admin | 7.83M | 4.85M | 2.31M | 445.80K |
Research & Development | 5.50M | 4.94M | 2.54M | 248.97K |
Other Expenses | 570.55K | 27.36K | 16.13K | - |
Operating Expenses | 13.91M | 9.81M | 4.87M | 694.77K |
Interest Expense | - | 2.43M | - | 38.98K |
Selling & Marketing Expenses | - | - | - | 445.13K |
Cost & Expenses | 13.91M | 9.81M | 4.87M | 694.77K |
Income Tax | 723.85K | 2.43M | -21.48K | -704.65 |
Shares Outstanding (Basic) | 10.16M | 9.95M | 9.68M | 9.68M |
Shares Outstanding (Diluted) | 10.16M | 9.95M | 9.68M | 9.68M |
EPS (Basic) | -0.79 | -1.48 | -0.5 | -0.08 |
EPS (Diluted) | -0.79 | -1.48 | -0.5 | -0.08 |
EBITDA | -7.90M | -12.22M | -4.85M | 10.44K |
Depreciation & Amortization | 27.36K | 27.36K | 16.13K | 704.65K |